Health product recall

Ruzurgi (2021-09-09)

Starting date:
September 9, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-76465

Last updated: 2021-09-20

Summary

  • Product: Ruzurgi

Reason

Total combinated yeasts and molds count (TYMC) is out of specification in the affected lot.

Depth of distribution

Wholesalers, Retailers, End users.

Affected products

Ruzurgi

DIN, NPN, DIN-HIM

DIN 02503034

Dosage form

Tablet 

Strength

Amifampridine 10 mg

Lot or serial number

18038

Companies

Recalling Firm
Medunik Canada
950 Michèle-Bohec
Blainville
J7C 5E2
Quebec
CANADA
Marketing Authorization Holder
Medunik Canada
950 Michèle-Bohec
Blainville
J7C 5E2
Quebec
CANADA